SecBot SecBot
144 ·Filed Sep 21, 2026

AMPH

Amphastar Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago SEC0001969223-26-001034
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to the company's market cap and appears to be a routine diversification move following RSU vesting. Monitor for any subsequent Form 4 filings to confirm execution, but no immediate market impact is expected.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
AMPH ▲ +6.66% at T+20d
NEUTRAL call +6.66% · α vs SPY +7.22% · entry $24.32 → $25.94
Next anchor: T+60d in 7w
Latest observation: T+23 -5.10% FF3 residual α
Entry = T+0 close
Sep 21, 2026
via day close
T+1d
+2.63%
call +2.63% · α +3.35%
$24.96
settled 5w ago
T+5d
+9.70%
call +9.70% · α +10.89%
$26.68
settled 28d ago
T+20d
+6.66%
call +6.66% · α +7.22%
$25.94
settled 7d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

William J. Peters, an officer of Amphastar Pharmaceuticals, filed a Form 144 notice of intent to sell 4,139 shares of common stock, with an estimated aggregate market value of approximately $103,475. The shares were acquired via RSU vesting on March 17, 2024. The filing is a routine advance notice of a proposed sale by an insider, with no indication of material non-public information or urgency.

Key Facts

  • Insider: William J. Peters (Officer)
  • Proposed sale: 4,139 shares of common stock
  • Estimated market value: ~$103,475
  • Shares acquired via RSU vesting on 03/17/2024
  • Broker: UBS Financial Services Inc.
  • Filing date: 09/21/2026

Financial Impact

Proposed sale of ~$103,475 in shares, representing a small fraction of the issuer's market cap (approximately $4.25 billion based on filing context).

dilution

Risk Factors

  • Insider selling could signal reduced conviction if followed by larger or more frequent filings.
  • Form 144 is an intent to sell; the actual sale may not occur.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-001034
Document: 0001969223-26-001034-index.html0001969223-26-001034
Document: 0001969223-26-001034.txt0001969223-26-001034
8 reports for AMPH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AMPH — sortable, filterable
TypeNow
Sep 23, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.27awaiting T+60—$25.32 (−3.62%)
Sep 21, 2026
4w ago
144
NEUTRAL ★ 2/10
$24.32awaiting T+60—$25.32 (+4.11%)
Aug 21, 2026
9w ago
Institutional Cluster
MIXED ★ 4/10
$21.60awaiting T+60—$25.32 (+17.22%)
Aug 12, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$20.18awaiting T+60—$25.32 (+25.47%)
Aug 11, 2026
10w ago
144
NEUTRAL ★ 2/10
$20.31awaiting T+60—$25.32 (+24.67%)
Jul 13, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$19.29 $25.91▲ +34.32%▲ +30.32%$25.32 (+31.26%)
Jul 7, 2026
15w ago
8-K
BEARISH ★ 6/10
$18.88 $25.35▼ −34.27%▼ −31.78%$25.32 (−34.11%)
Apr 13, 2026
27w ago
DEFA14A
NEUTRAL ★ 3/10
$21.38 $19.02▼ −11.04%▼ −19.56%$25.32 (+18.43%)
Showing 8 of 8

US Market Status

Market Open — Closes in 1h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 21, 2026